These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The European pharmacopoeia]. Grainger H Dtsch Apoth Ztg; 1965 Sep; 105(35):1165-7. PubMed ID: 5858155 [No Abstract] [Full Text] [Related]
25. European pharmacopoeia. Br Med J; 1970 Feb; 1(5694):449. PubMed ID: 5435143 [No Abstract] [Full Text] [Related]
26. [Towards a second edition of the European Pharmacopoeia]. Moreau RC Bull Acad Natl Med; 1979 May; 163(5):420-3. PubMed ID: 15648332 [No Abstract] [Full Text] [Related]
27. [Substances of reference in the European Pharmacopoeia]. Pharm Acta Helv; 1978; 53(5):136-8. PubMed ID: 724725 [No Abstract] [Full Text] [Related]
28. European Pharmacopoeia--state of the art. Grainger HS Bull Parenter Drug Assoc; 1977; 31(2):79-85. PubMed ID: 851672 [No Abstract] [Full Text] [Related]
29. [Checking of apparatus in the European Pharmacopoeia]. Bouché R; Molle L J Pharm Belg; 1975; 30(5-6):578-84. PubMed ID: 1214209 [No Abstract] [Full Text] [Related]
30. The revision of the Inhalanda monograph of the European Pharmacopoeia. Olsson B J Aerosol Med; 1998; 11 Suppl 1():S13-6. PubMed ID: 10180725 [No Abstract] [Full Text] [Related]
31. [Monographs on antibiotics in the European Pharmacopoeia (Vol. II)]. Vanderhaeghe H J Pharm Belg; 1975; 30(5-6):497-518. PubMed ID: 1214206 [No Abstract] [Full Text] [Related]
32. Review on crystal polymorphism of substances in the European pharmacopoeia. Borka L Pharm Acta Helv; 1991; 66(1):16-22. PubMed ID: 1758886 [TBL] [Abstract][Full Text] [Related]
33. [Methods of analysis of inorganic substances in the European Pharmacopoeia]. Rondelet J J Pharm Belg; 1975; 30(5-6):519-48. PubMed ID: 1214207 [No Abstract] [Full Text] [Related]
34. [On the National Institute Sciences Standard (the Japanese Pharmacopoeia Standard) "Cyanocobalamin Reference Standard (Control 801)" (author's transl)]. Ohta M; Kimura T; Kawamura J Eisei Shikenjo Hokoku; 1981; 99():113-4. PubMed ID: 7332797 [No Abstract] [Full Text] [Related]
35. [On the National Institute of Hygienic Sciences Standard (Japanese Pharmacopoeia Standard "Progesterone Reference Standard (Control 721)" (author's transl)]. Ohta M; Kimura T; Kawamura J Eisei Shikenjo Hokoku; 1981; 99():115-8. PubMed ID: 7332798 [No Abstract] [Full Text] [Related]
36. Combined vaccines: policy and practice in the European Pharmacopoeia. Castle P Biologicals; 1994 Dec; 22(4):381-7. PubMed ID: 7779365 [No Abstract] [Full Text] [Related]
37. [Certification of suitability of monographs of the European pharmacopoeia]. Artiges A Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143 [TBL] [Abstract][Full Text] [Related]
38. [On the National Institute of Hygienic Sciences Standard (the Japanese Pharmacopoeia Standard) "G-Strophanthin Reference Standard" (author's transl)]. Tokunaga H; Kimura T; Kawamura J Eisei Shikenjo Hokoku; 1973; 91(0):63-4. PubMed ID: 4800113 [No Abstract] [Full Text] [Related]
39. [On the National Institute of Hygienic Sciences Standard (the Japanese Pharmacopoeia Standard) "Lanatoside C reference Standard" (author's transl)]. Tokunaga H; Kimura T; Kawamura J Eisei Shikenjo Hokoku; 1973; 91(0):61-2. PubMed ID: 4800114 [No Abstract] [Full Text] [Related]
40. [Commentaries on the monographs of Group 10 in Volumes I and II of the European Pharmacopoeia]. Bosly J; De Moerloose P J Pharm Belg; 1975; 30(5-6):549-77. PubMed ID: 1214208 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]